I like the look of this - Plenty of news to come no doubt - what else have we got to mark progress then results from clinical trials.. obviously money is needed as has always been the case - management need to keep costs down and make sure the trials are targetted for a specific outcome not doing trials for the sake of doing trials or never ending phase1's...but that isn't the case here:
